Literature DB >> 30128780

In Silico Prediction of Diffusion Interaction Parameter (kD), a Key Indicator of Antibody Solution Behaviors.

Dheeraj S Tomar1, Satish K Singh1,2, Li Li3, Matthew P Broulidakis4,5, Sandeep Kumar6,7.   

Abstract

PURPOSE: To develop resource-sparing in silico approaches that aim to reduce experimental effort and material required by developability assessments (DA) of monoclonal antibody (mAb) drug candidates.
METHODS: A battery of standardized biophysical experiments was performed on high concentration formulations of 16 drug product development stage mAbs using a platform buffer. Full-length molecular models of these mAbs were also generated via molecular modeling. These models were used to computationally estimate molecular descriptors of these 16 mAbs. Pairwise and multi-parameter correlations among experimentally measured biophysical attributes and calculated molecular descriptors were obtained via statistical analyses.
RESULTS: Diffusion interaction parameter (kD) showed statistically significant pairwise correlations (p-values <0.005) with thermal stability, viscosity, isoelectric point, and apparent solubility of the antibodies in our dataset. kD also showed statistically significant pairwise correlations (p-values <0.005) with several computationally calculated molecular descriptors (pI, net charge, charge on the Fv region, and zeta potential.) These pairwise correlations were further refined by multivariate analyses. These analyses yielded several useful equations for prediction of kD from antibody sequences, structural models, and experimentally measured biophysical attributes.
CONCLUSIONS: Diffusion interaction parameter (kD) was found to be a key biophysical property for the mAbs in our dataset. It connects conformational heterogeneity of an antibody with its colloidal and rheological behaviors. The equations derived in this work shall enable rapid, resource-sparing, and cost-effective DAs of biologic drug candidates.

Keywords:  biopharmaceutical informatics; diffusion interaction parameter; high concentration; molecular modeling; monoclonal antibody

Mesh:

Substances:

Year:  2018        PMID: 30128780     DOI: 10.1007/s11095-018-2466-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  59 in total

1.  Correlation between the osmotic second virial coefficient and the solubility of proteins.

Authors:  S Ruppert; S I Sandler; A M Lenhoff
Journal:  Biotechnol Prog       Date:  2001 Jan-Feb

2.  Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.

Authors:  Veysel Kayser; Naresh Chennamsetty; Vladimir Voynov; Kurt Forrer; Bernhard Helk; Bernhardt L Trout
Journal:  Biotechnol J       Date:  2011-01       Impact factor: 4.677

3.  Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions.

Authors:  Mariya Pindrus; Steven J Shire; Robert F Kelley; Barthélemy Demeule; Rita Wong; Yiren Xu; Sandeep Yadav
Journal:  Mol Pharm       Date:  2015-10-06       Impact factor: 4.939

4.  Targeted purification development enabled by computational biophysical modeling.

Authors:  Francis K Insaidoo; Michael A Rauscher; Shepard J Smithline; Niels C Kaarsholm; Bradley P Feuston; Allison D Ortigosa; Thomas O Linden; David J Roush
Journal:  Biotechnol Prog       Date:  2014-12-19

5.  In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.

Authors:  Vikas K Sharma; Thomas W Patapoff; Bruce Kabakoff; Satyan Pai; Eric Hilario; Boyan Zhang; Charlene Li; Oleg Borisov; Robert F Kelley; Ilya Chorny; Joe Z Zhou; Ken A Dill; Trevor E Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

6.  In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions.

Authors:  Dheeraj S Tomar; Li Li; Matthew P Broulidakis; Nicholas G Luksha; Christopher T Burns; Satish K Singh; Sandeep Kumar
Journal:  MAbs       Date:  2017-01-26       Impact factor: 5.857

Review 7.  Biopharmaceutical Informatics: supporting biologic drug development via molecular modelling and informatics.

Authors:  Sandeep Kumar; Nikolay V Plotnikov; Jason C Rouse; Satish K Singh
Journal:  J Pharm Pharmacol       Date:  2017-02-03       Impact factor: 3.765

8.  Impact of deglycosylation and thermal stress on conformational stability of a full length murine IgG2a monoclonal antibody: observations from molecular dynamics simulations.

Authors:  Xiaoling Wang; Sandeep Kumar; Patrick M Buck; Satish K Singh
Journal:  Proteins       Date:  2012-11-12

9.  Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.

Authors:  James C Geoghegan; Ryan Fleming; Melissa Damschroder; Steven M Bishop; Hasige A Sathish; Reza Esfandiary
Journal:  MAbs       Date:  2016-04-06       Impact factor: 5.857

10.  The concentration-dependence of macromolecular parameters.

Authors:  S E Harding; P Johnson
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

View more
  10 in total

1.  Multiscale Coarse-Grained Approach to Investigate Self-Association of Antibodies.

Authors:  Saeed Izadi; Thomas W Patapoff; Benjamin T Walters
Journal:  Biophys J       Date:  2020-04-29       Impact factor: 4.033

2.  Use of Debye-Hückel-Henry charge measurements in early antibody development elucidates effects of non-specific association.

Authors:  Joshua R Laber; Thomas M Laue; Dana I Filoti
Journal:  Antib Ther       Date:  2022-07-28

3.  An adapted consensus protein design strategy for identifying globally optimal biotherapeutics.

Authors:  Yanyun Liu; Kenny Tsang; Michelle Mays; Gale Hansen; Jeffrey Chiecko; Maureen Crames; Yangjie Wei; Weijie Zhou; Chase Fredrick; James Hu; Dongmei Liu; Douglas Gebhard; Zhong-Fu Huang; Akshita Datar; Anthony Kronkaitis; Kristina Gueneva-Boucheva; Daniel Seeliger; Fei Han; Saurabh Sen; Srinath Kasturirangan; Justin M Scheer; Andrew E Nixon; Tadas Panavas; Michael S Marlow; Sandeep Kumar
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

4.  Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

Authors:  Adriana-Michelle Wolf Pérez; Nikolai Lorenzen; Michele Vendruscolo; Pietro Sormanni
Journal:  Methods Mol Biol       Date:  2022

5.  Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies.

Authors:  Cholpon Tilegenova; Saeed Izadi; Jianping Yin; Christine S Huang; Jiansheng Wu; Diego Ellerman; Sarah G Hymowitz; Benjamin Walters; Cleo Salisbury; Paul J Carter
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

6.  Development of QSAR models for in silico screening of antibody solubility.

Authors:  Xuan Han; James Shih; Yuhao Lin; Qing Chai; Steven M Cramer
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

7.  Mitigation of liquid-liquid phase separation of a monoclonal antibody by mutations of negative charges on the Fab surface.

Authors:  Tatsuji Matsuoka; Ryuki Miyauchi; Nobumi Nagaoka; Jun Hasegawa
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

8.  A single molecular descriptor to predict solution behavior of therapeutic antibodies.

Authors:  Jonathan S Kingsbury; Amandeep Saini; Sarah Marie Auclair; Li Fu; Michaela M Lantz; Kevin T Halloran; Cesar Calero-Rubio; Walter Schwenger; Christian Y Airiau; Jifeng Zhang; Yatin R Gokarn
Journal:  Sci Adv       Date:  2020-08-05       Impact factor: 14.136

9.  Computational approaches to therapeutic antibody design: established methods and emerging trends.

Authors:  Richard A Norman; Francesco Ambrosetti; Alexandre M J J Bonvin; Lucy J Colwell; Sebastian Kelm; Sandeep Kumar; Konrad Krawczyk
Journal:  Brief Bioinform       Date:  2020-09-25       Impact factor: 11.622

10.  Intrinsic physicochemical profile of marketed antibody-based biotherapeutics.

Authors:  Lucky Ahmed; Priyanka Gupta; Kyle P Martin; Justin M Scheer; Andrew E Nixon; Sandeep Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.